Dergiler / Eurasian Journal of Pulmonology / 2020 / Cilt: 22 - Sayı: 1

Interstitial lung diseases and COVID‑19

Sayfa
61–66
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Thismanuscript details the pathophysiology of the new coronavirus associated with fibrosis and makesrecommendations for cases with interstitial lung disease.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:There is continued lack of knowledge of the physiopathology and recovery processes of the newcoronavirus pneumonia.
📊
Temel Bulgular & Veri:The Type I and Type II pneumocytes infected withthe human coronavirus (hCoV) play a critical role in mediating the lung pathology and host sensitivity.Both human and animal studies have demonstrated that an inflammatory process starts in the lungsfollowing hCoV infection and that an accumulation of monocyte–macrophage and neutrophils occurs.One of the earliest outcomes of rapid virus replication and increased proinflammatory cytokine/chemokine response is apoptosis of the epithelial and endothelial cells of the lung.
💡
Sonuç & Katkı:Thismanuscript details the pathophysiology of the new coronavirus associated with fibrosis and makesrecommendations for cases with interstitial lung disease.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

There is continued lack of knowledge of the physiopathology and recovery processes of the newcoronavirus pneumonia. The complications are similar to those experienced with severe acuterespiratory syndrome and Middle East respiratory syndrome, since the new coronavirus is part ofthe same family. The new coronavirus infects both the epithelial cells of the airway and also alveolarepithelial cells (Type I and Type II pneumocyte). The Type I and Type II pneumocytes infected withthe human coronavirus (hCoV) play a critical role in mediating the lung pathology and host sensitivity.Both human and animal studies have demonstrated that an inflammatory process starts in the lungsfollowing hCoV infection and that an accumulation of monocyte–macrophage and neutrophils occurs.One of the earliest outcomes of rapid virus replication and increased proinflammatory cytokine/chemokine response is apoptosis of the epithelial and endothelial cells of the lung. The main effectof the new coronavirus on the body is an imbalance in the ratio of the cytokines produced by thebody in response to the abnormal immune reaction, resulting from the invasion of the virus. Thismanuscript details the pathophysiology of the new coronavirus associated with fibrosis and makesrecommendations for cases with interstitial lung disease.

🔖

Bu Makaleye Atıf Yap

GULHAN, P. Y., YAZICI, O., DEMİRCİ, N., BOZKUS, F., COSKUN, F. (2022). Interstitial lung diseases and COVID‑19. Eurasian Journal of Pulmonology, Cilt: 22 - Sayı: 1, 61–66. https://ajindex.com/articles/509616

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. World Health Organization. WHO Characterizes COVID‑19 as a Pandemic [EB/OL]. World Health Organization; 2020. Available from: https://www.who.int/emergencies/dise ases/ novel‑coronavirus‑2019/events‑as‑they‑happen. [Last accessed 2020 Apr 20]
  2. World Health Organization. Situation Report‑81 Coronavirus Disease 2019 (COVID‑19)[EB/OL]. World Health Organization; 2020. Available from: https://www.who.int/docs/default‑sou rce/coronaviruse/situation‑reports/20200314‑sitrep‑81‑covid‑19. pdf?sfvrsn=dcd46351_2. [Last accessed 2020 Apr 20]
  3. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39:529‑39
  4. Hosseiny M, Kooraki S, Gholamrezanezhad A, Reddy S, Myers L. Radiology perspective of coronavirus disease 2019 (COVID‑19): Lessons from severe acute respiratory syndrome and middle east respiratory syndrome. AJR Am J Roentgenol 2020;214:1078‑82
  5. Channappanavar R, Fehr AR, Vijay R, Mack M, Zhao J, Meyerholz DK, et al. Dysregulated type I interferon and inflammatory monocyte‑macrophage responses cause lethal pneumonia in SARS‑CoV‑infected mice. Cell Host Microbe 2016;19:181‑93
  6. Chu CM, Poon LL, Cheng VC, Chan KS, Hung IF, Wong MM, et al. Initial viral load and the outcomes of SARS. CMAJ 2004;171:1349‑52
  7. Ng ML, Tan SH, See EE, Ooi EE, Ling AE. Proliferative growth of SARS coronavirus in Vero E6 cells. J Gen Virol 2003;84:3291‑303
  8. Oh MD, Park WB, Choe PG, Choi SJ, Kim JI, Chae J, et al. Viral load kinetics of MERS coronavirus infection. N Engl J Med 2016;375:1303‑5
  9. Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, et al. Lung pathology offatal severe acute respiratory syndrome. Lancet 2003;361:1773‑8
  10. Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, Pleschka S, et al. Lung epithelial apoptosis in influenza virüs pneumonia: The role of macrophage‑expressed TNF‑related apoptosis‑inducing ligand. J Exp Med 2008;205:3065‑77
  11. Högner K, Wolff T, Pleschka S, Plog S, Gruber AD, Kalinke U,et al. Macrophage‑expressed IFN‑β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog 2013;9:e1003188
  12. Rodrigue‑Gervais IG, Labbé K, Dagenais M, Dupaul‑Chicoine J, Champagne C, Morizot A, et al. Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival. Cell Host Microbe 2014;15:23‑35